Read on the application
The year 2023 was very special for veteran stock market investor Rekha Jhunjhunwala. This year the portfolio value of the shares is Rs. 14,428 crore or an increase of about 44 percent. During this period, Rekha Jhunjhunwala has made strong gains from shares of Tata Motors Limited and Titan Company Limited. At the same time another stock Concorde Biotech has given a strong return on listing. Rekha Jhunjhunwala’s share portfolio at the end of 2022 will be Rs. 48,108.40 crore, which at the end of 2022 was Rs. 33,518 crore increased by 43.53 percent to Rs.
Return of the Titans
Shares of Jhunjhunwala’s largest stock, Titan, rose 44.90 percent for the year. As of September 30, Jhunjhunwala held a 5.37 percent stake in the Tata group company, valued at Rs. 17,731.90 crores.
Shares of Tata Motors
Jhunjhunwala also has a large stake in Tata Motors. In the year 2023, it increased to 88.96 percent. Tata Motors is indeed the best performing Nifty stock for 2023. According to Trendline, Jhunjhunwala paid Tata Motors Rs. 3,968.90 crore shares.
Concord Biotech
Concorde Biotech was listed last August. The stock also gave solid returns on listing. Let us tell you that Rekha’s late husband Rakesh Jhunjhunwala was an investor in the company since 2004. On Thursday, the stock traded at Rs. 1,462.15, compared to its Rs. 741 was 97 percent above its issue price.
Position of other stocks
Metro Brands jumped 48 percent year-on-year, while Crisil advanced 44 percent in the same period. Canara Bank shares have gained 31 percent, better than the Sensex’s return of 18 percent over the same period. Fortis Healthcare (44 per cent), NCC (84 per cent) and Indian Hotels (38 per cent) also returned well. Among Jhunjhunwala’s top 10 holdings, only Star Health and Allied Insurance Company Limited had a negative return of 8.74 per cent.